DAZAP1 and gastric cancer: Transwell assays further indicated that DAZAP1 knockdown markedly inhibited the migration and invasiveness of GC cells, while DAZAP1 overexpression enhanced these abilities (Figure 3E and Supplemental Figure 2D).